Clinical Research Directory
Browse clinical research sites, groups, and studies.
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
Sponsor: Regeneration Biomedical, Inc.
Summary
This is a research study to evaluate the safety of an investigational autologous cell product obtained from participant's own adipose tissue as a possible treatment for Alzheimer disease.
Official title: Ph 1, Open-Label Safety Study of Escalating Doses of Intracerebroventricular Injections of Ex Vivo Expanded, Autologous ADSCs in Participants With Mild-Moderate AD Whose Treatment is Not Addressed Adequately by Available Therapy
Key Details
Gender
All
Age Range
45 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
18
Start Date
2023-08-14
Completion Date
2026-08
Last Updated
2025-04-04
Healthy Volunteers
No
Conditions
Interventions
RB-ADSC
Ex Vivo Expanded, Autologous Adipose-Derived Stem Cells (ADSCs)
Locations (1)
Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States